| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/06/1999 | US5919491 Calcium salt encapsulated in hydrophilic matrix polymer |
| 07/06/1999 | US5919451 Feeding the animal feed particles having an inner core of nutrients and an outer layer containing a conjugated fatty acid or an antibody that can protect the animal from contacting diseases that can adversely affect the animal's |
| 07/06/1999 | CA2177146C Heterocyclic benzenesulfonylimine derivatives as inhibitors of il-1 action |
| 07/06/1999 | CA2157397C Indole derivatives as 5-ht1-like agonists for use in migraine |
| 07/06/1999 | CA2082296C Process for the preparation of stable, complex emulsion systems of the water-oil-type and their use as cosmetic preparations |
| 07/01/1999 | WO1999032520A1 Method for quantitating denatured ldls |
| 07/01/1999 | WO1999032518A1 A dna molecule encoding a mutant prepro-neuropeptide y, a mutant signal peptide, and uses thereof |
| 07/01/1999 | WO1999032487A1 Kv2.1 ANTAGONISTS |
| 07/01/1999 | WO1999032482A1 Hypoglycemic imidazoline compounds |
| 07/01/1999 | WO1999032476A1 Carboxyl substituted chroman derivatives useful as beta 3 adrenoreceptor agonists |
| 07/01/1999 | WO1999032475A1 Novel sulfonamide substituted chroman derivatives useful as beta-3 adrenoreceptor agonists |
| 07/01/1999 | WO1999032465A1 Arylthiazolidinedione derivatives |
| 07/01/1999 | WO1999032460A1 Substituted 2-aryl-4-amino-chinazolines, method for the production and use thereof as medicaments |
| 07/01/1999 | WO1999032451A1 Azepine or larger medium ring derivatives and their use as pharmaceuticals |
| 07/01/1999 | WO1999032448A1 Substituted pyridine and pyridazine compounds and their pharmaceutical use |
| 07/01/1999 | WO1999032437A1 1,3-disubstituted ureas as acat inhibitors, and method of preparing thereof |
| 07/01/1999 | WO1999032142A1 Beta-lipotropin and uses thereof |
| 07/01/1999 | WO1999032116A1 Insoluble compositions for controlling blood glucose |
| 07/01/1999 | WO1999032112A1 Method for treating diabetes |
| 07/01/1999 | WO1999032111A1 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS |
| 07/01/1999 | WO1999018801A9 Methods and compositions for the treatment of autoimmune disease using heat shock proteins |
| 07/01/1999 | WO1999015167A3 Use of citrus limonoids and flavonoids as well as tocotrienols for the treatment of cancer |
| 07/01/1999 | DE19757414A1 Fettmischung Fatblend |
| 07/01/1999 | CA2316971A1 Carboxyl substituted chroman derivatives useful as beta 3 adrenoreceptor agonists |
| 07/01/1999 | CA2315888A1 Beta-lipotropin and uses thereof |
| 07/01/1999 | CA2315720A1 Inhibition of p38 kinase activity using substituted heterocyclic ureas |
| 07/01/1999 | CA2315300A1 Insoluble compositions for controlling blood glucose |
| 07/01/1999 | CA2315280A1 Method for quantifying denatured ldl |
| 07/01/1999 | CA2315226A1 Hypoglycemic imidazoline compounds |
| 07/01/1999 | CA2314925A1 Novel sulfonamide substituted chroman derivatives useful as beta-3 adrenoreceptor agonists |
| 07/01/1999 | CA2314614A1 A dna molecule encoding a mutant prepro-neuropeptide y, a mutant signal peptide, and uses thereof |
| 06/30/1999 | EP0926239A2 Beta-lipotropin and uses thereof |
| 06/30/1999 | EP0926145A1 Napthalene compounds, method for their preparation and pharmaceutical compositions containing them |
| 06/30/1999 | EP0925792A2 Insoluble compositions for controlling blood glucose |
| 06/30/1999 | EP0925503A1 Materials and methods relating to the diagnosis and treatment of diabetes and obesity |
| 06/30/1999 | EP0925305A1 Cyclitol containing carbohydrates from human tissue which regulate lipogenic activity |
| 06/30/1999 | EP0925299A1 Pyrazolopyridine compound and pharmaceutical use thereof |
| 06/30/1999 | EP0925298A1 Substituted 6,6-hetero-bicyclic derivatives |
| 06/30/1999 | EP0925293A1 Method of producing an extruded nutritional supplement product |
| 06/30/1999 | EP0925273A1 Pharmaceutical composition containing 4-oxo-butynic acids |
| 06/30/1999 | EP0925072A2 Method for lowering cholesterol levels |
| 06/30/1999 | EP0925071A1 Muc-1 as an immunosuppressive therapeutic agent for the treatment of inflammatory and autoimmune conditions |
| 06/30/1999 | EP0924986A1 Antioxidant derived from lentil and its preparation and uses |
| 06/30/1999 | EP0756602B1 Cck or gastrin modulating 5-heterocyclic-1,5-benzodiazepines |
| 06/30/1999 | EP0466768B2 Short-chain triglycerides |
| 06/30/1999 | CN1221426A Fragments of leptin (OB protein) |
| 06/30/1999 | CN1221417A Thiazolidinedione compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions thereof |
| 06/30/1999 | CN1221414A Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 06/30/1999 | CN1221410A Novel substituted 2,4-thiazolidine diketone derivatives, method for preparation thereof and pharmaceutical compositions containing the same |
| 06/30/1999 | CN1221347A Medicament for optimising mucosal viscosity and stimulating intestinal function |
| 06/30/1999 | CN1221344A Extractable compounds and method for making and using the same |
| 06/30/1999 | CN1221339A Use of inhibitors of cellular Na+/H+ exchanger (NHE) for preparing medicament for normalizing serum lipids |
| 06/29/1999 | US5917047 Heterocyclic compounds |
| 06/29/1999 | US5917027 Nucleic acids encoding potassium-channel proteins |
| 06/29/1999 | US5917014 Methods of treating inflammation and compositions therefor |
| 06/29/1999 | US5917007 Alkylated and crosslinked polyallylamine, polyvinylamine, polyethylenimine or diethylenetriamine-epichlorohydrin copolymer |
| 06/29/1999 | US5916923 Venlafaxine for the treatment of generalized anxiety disorder |
| 06/29/1999 | US5916901 Heterocyclic compounds |
| 06/29/1999 | US5916889 1,4-disubstituted piperazines |
| 06/29/1999 | US5916790 Encapsulation compositions, and methods |
| 06/29/1999 | US5916567 Powdered inner seed and powdered fibrous outer shell subjected to radiation |
| 06/29/1999 | US5916555 Pharmaceutical composition for treatment of diabetes |
| 06/29/1999 | CA1340614C Cyclopentano-vitamin d analogs |
| 06/29/1999 | CA1340612C Cell specific cytotoxic agents derived from diphtheria toxin |
| 06/24/1999 | WO1999031232A1 Human brain derived kcnq2 potassium channel |
| 06/24/1999 | WO1999031134A1 Glucose regulated gene |
| 06/24/1999 | WO1999031112A1 Vitamin d derivatives with phosphorous atoms in the side chains |
| 06/24/1999 | WO1999031099A1 Integrin receptor antagonists |
| 06/24/1999 | WO1999031095A1 5-[4-[2- (n-methyl-n- (2-pyridyl)amino) ethoxy]benzyl] thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical |
| 06/24/1999 | WO1999031094A1 Hydrate of 5-[4-[2- (n-methyl-n- (2-pyridil)amino) ethoxy]benzyl] thiazolidine-2, 4-dione maleic acid salt |
| 06/24/1999 | WO1999031093A1 Substituted thiazolidinedione derivative, process for its preparation and its pharmaceutical use |
| 06/24/1999 | WO1999031085A1 3-piperidyl-4-oxoquinazoline derivatives and medicincal compositions containing the same |
| 06/24/1999 | WO1999031077A1 Arylpiperazines having activity at the serotonin 1a receptor |
| 06/24/1999 | WO1999031066A1 Pyridones as src family sh2 domain inhibitors |
| 06/24/1999 | WO1999031061A1 Integrin receptor antagonists |
| 06/24/1999 | WO1999031058A1 Novel heterocyclic compounds |
| 06/24/1999 | WO1999031045A1 Phenylaminoalkylcarboxylic acid derivatives and medicinal compositions containing the same |
| 06/24/1999 | WO1999030740A1 Method for enhancing the absorption and transport of lipid soluble compounds using structured glycerides |
| 06/24/1999 | WO1999030708A2 Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men and method to study the dyssynergia in male rodents |
| 06/24/1999 | WO1999030706A1 ANTIHYPERLIPIDEMIC STATIN-LP(a) INHIBITOR COMBINATIONS |
| 06/24/1999 | WO1999030704A1 Statin-carboxyalkylether combinations |
| 06/24/1999 | WO1999030687A1 Pharmaceutical compositions containing micronized bicyclic drugs |
| 06/24/1999 | WO1999030670A2 Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof |
| 06/24/1999 | DE19756388A1 New 2-aryl-4-amino-6,7-di:methoxy-quinazoline derivatives useful as guanylate cyclase activators for treating cardiovascular diseases, etc. |
| 06/24/1999 | CA2586240A1 Improved hmg coa reductase inhibitor extended release formulation |
| 06/24/1999 | CA2506802A1 Arylpiperazines having activity at the serotonin 1a receptor |
| 06/24/1999 | CA2315224A1 Method for enhancing the absorption and transport of lipid soluble compounds using structured glycerides |
| 06/24/1999 | CA2314968A1 Pharmaceutical compositions containing micronized bicyclic drugs |
| 06/24/1999 | CA2314967A1 Substituted thiazolidinedione derivative, process for its preparation and its pharmaceutical use |
| 06/24/1999 | CA2314965A1 Hydrate of 5-[4-[2- (n-methyl-n- (2-pyridil)amino) ethoxy]benzyl] thiazolidine-2, 4-dione maleic acid salt |
| 06/24/1999 | CA2314141A1 Glucose regulated gene |
| 06/24/1999 | CA2314107A1 5-[4-[2- (n-methyl-n- (2-pyridyl)amino) ethoxy]benzyl] thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical |
| 06/24/1999 | CA2312347A1 Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men and method to study the dyssynergia in male rodents |
| 06/24/1999 | CA2304612A1 Statin-carboxyalkylether combinations |
| 06/24/1999 | CA2299397A1 Antihyperlipidemic statin-lp(a) inhibitor combinations |
| 06/24/1999 | CA2280705A1 3-piperidyl-4-oxoquinazoline derivatives and pharmaceutical compositionscomprising the same |
| 06/23/1999 | EP0924209A1 Hypoglycemic imidazoline compounds |
| 06/23/1999 | EP0924205A1 Arylpiperazines having activity at the serotonin 1a receptor |
| 06/23/1999 | EP0923936A2 Flavor-improved extract from Cassia mimosoides L. var. nomame Makino and method of preparing the same |
| 06/23/1999 | EP0923582A1 Substituted 6,5-hetero-bicyclic derivatives |